Rimceft-TGM 250mg/31.25mg Injection
Marketer
Sarian Healthcare
Salt Composition
Ceftriaxone (250mg) + Tazobactum (31.25mg)
Overview Rimceft-TGM 250mg/31.25mg Injection
Ceftolozane/Tazobactam 250mg/31.25mg injection is a dual-action antibiotic used to combat diverse bacterial infections. Its mechanism inhibits bacterial growth and proliferation. Administration should always be under a doctor's direct supervision; strict adherence to the prescribed dosage schedule is crucial for efficacy. Completing the entire course of treatment is essential, even with symptom improvement, as premature cessation may compromise its effectiveness. Commonly reported side effects include gastrointestinal upset (nausea, vomiting, diarrhea, dyspepsia). Severe or worsening side effects necessitate immediate medical attention. Allergic reactions (skin rashes, itching, swelling, respiratory distress) demand immediate emergency care. Prior to commencing treatment, inform your physician of all current medications and any pre-existing medical conditions. Pregnant or lactating individuals require specific medical counsel before use. Alcohol consumption should be avoided due to potential additive drowsiness. While generally not impairing driving ability, refrain from driving if experiencing somnolence or dizziness. Adequate rest, proper nutrition, and sufficient hydration contribute to optimal recovery. Your physician may order blood tests and other diagnostic procedures to monitor treatment response.
Uses of Rimceft-TGM 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Rimceft-TGM 250mg/31.25mg Injection:
This medication will be administered by your physician or their qualified assistant; self-medication is strongly discouraged.
Common Side effects of Rimceft-TGM 250mg/31.25mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Rimceft-TGM 250mg/31.25mg Injection:
This medication will be administered by your physician or their designated nurse; please do not attempt self-medication.
How Rimceft-TGM 250mg/31.25mg Injection works:
Ceftriaxone/Tazobactam (Rimceft-TGM 250mg/31.25mg Injection) combines a cephalosporin antibiotic with a beta-lactamase inhibitor. Ceftriaxone's antibacterial action disrupts bacterial cell wall synthesis, hindering bacterial survival. Tazobactam, by neutralizing beta-lactamases, strengthens Ceftriaxone's efficacy and overcomes bacterial resistance mechanisms.
SAFETY ADVICE
AlcoholSAFE
Ingestion of alcohol alongside Rimceft-TGM 250mg/31.25mg Injection poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Rimceft-TGM 250mg/31.25mg is typically deemed safe for use in pregnancy. Preclinical trials in animals revealed minimal or no harmful effects on fetal development; nevertheless, data from human trials remain scarce.
Breast feedingCAUTION
The administration of Rimceft-TGM 250mg/31.25mg Injection necessitates careful consideration during lactation. Breastfeeding is advised against until maternal treatment concludes and the medication is fully cleared from the mother's system.
DrivingUNSAFE
The administration of Rimceft-TGM 250mg/31.25mg Injection could reduce attentiveness, impair vision, and induce drowsiness or dizziness. Refrain from driving if any of these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Rimceft-TGM 250mg/31.25mg Injection to individuals with renal impairment. Physician consultation is recommended.
LiverCAUTION
For individuals with severe hepatic impairment, administration of Rimceft-TGM 250mg/31.25mg Injection requires careful consideration and potential dosage modification. Medical advice is essential. Dosage alteration of Rimceft-TGM 250mg/31.25mg Injection is unnecessary for patients exhibiting mild to moderate liver dysfunction.
What if you forget to take Rimceft-TGM 250mg/31.25mg Injection :
Should you inadvertently omit a scheduled dose of Rimceft-TGM 250mg/31.25mg Injection, seek immediate medical advice.
Facts to Know About Rimceft-TGM 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Anti-Infective Agents |
3,018 People bought this recently